Note: Front Cover -- Table of Contents -- In Memoriam: Robert A. Good -- Editors -- Contributors -- Chapter 1. Behavioral Effects of Cytokines: A Psychiatrist& -- #8217 -- s Perspective -- Chapter 2. Worried to Death? Stress, Worry, and Immune Dysregulation in Health and HIV -- Chapter 3. Psychological Stress and Its Relationship to Cytokines and Inflammatory Diseases -- Chapter 4. Role of Cytokines in Depression -- Chapter 5. Loneliness, Dysphoria, Stress, and Immunity: A Role for Cytokines -- Chapter 6. Stress, Cytokines, and Peripheral Analgesia -- Chapter 7. Alexithymia, Stress, and Immunity -- Chapter 8. Roles of Mu-Opioid Receptor and Endogenous Opiates in Stress-Induced Immunosuppression -- Chapter 9. Stress, Opioid Peptides, and Immune Response -- Chapter 10. Met-Enkephalin in Oxidative Stress -- Chapter 11. Chronic Stress Induces Death of Lymphocytes -- Chapter 12. Interleukin-10 and the Hypothalamic& -- #8211 -- Pituitary& -- #8211 -- Adrenal Axis -- Chapter 13. Cytokines, Stress, and Depression -- Chapter 14. Immunoconversion in Acute Phase Response -- Chapter 15. Interferon in Health and Disease -- Chapter 16. Neuropeptide Precursor Processing in Immunocytes: Involvement in Neuroimmune Communication -- Chapter 17. Clinical Relevance of Opioid-Induced Immunosuppression: Are All Drugs Similar? -- Chapter 18. Human Retroviruses and the Cytokine Network -- Chapter 19. Psychiatric Toxicity of Interferon-a: A Model for Understanding the Etiology of Major Depression and Chronic Fatigue Syndrome? -- Chapter 20. Role of Genetic Predisposition, Cytokines, and Neuroendocrine Response in Development of Thyroid Autoimmunity -- Chapter 21. Gender Differences, Stress, and Immunity* -- Index -- Back Cover.

Note: Front Cover -- Clinical Immunobiology -- Copyright Page -- Table of Contents -- List of Contributors -- Preface -- Contents of Previous Volumes -- Chapter 1. Evaluation of the Immunoglobulins -- I. Introduction -- II. Techniques -- III. Results -- IV. Summary -- References -- Chapter 2. Electrophoresis and Immunoelectrophoresis in the Evaluation of Homogeneous Immunoglobulin Components -- I. Introduction -- II. Homogeneous Proteins in Disease States -- III. Techniques for Characterization and Quantitation of Homogeneous Immunoglobulin Components -- IV. Evaluation of Test Results -- V. Conclusions -- References -- Chapter 3. Serum Concentrations of IgG Subclasses -- I. Introduction -- II. Quantitative Determination of IgG Subclasses -- III. IgG Subclass Concentrations in Sera of Normal Individuals -- IV. Subclass Levels in Sera of Patients with Increased Concentrations of Total IgG -- V. IgG Subclasses in Primary Immunodeficiency Diseases -- VI. IgG Subclasses after Bone Marrow Transplantation in Severe Combined Immunodeficiency -- Acknowledgments -- References -- Chapter 4. Imbalances of the k/λ Ratio of Human Immunoglobulins -- I. Introduction -- II. Methods for Detection of Human Immunoglobulin Light-Chain Imbalances -- III. Analyses of Normal and Pathological Sera -- IV. Conclusions -- References -- Chapter 5. Metabolism of Immunoglobulins -- I. Introduction -- II. Methods Used in Immunoglobulin Turnover Studies -- III. Metabolism of Immunoglobulins in Normal Individuals -- IV. Problems in Interpretation of the Data -- V. Disorders of Immunoglobulin Metabolism -- VI. Summary -- References -- Chapter 6. Cell-Mediated Immunity: In Vivo Testing -- I. Introduction -- II. Skin Test Battery -- III. Results -- IV. Differential Diagnosis -- References -- Chapter 7. Cellular Immunity: Antibody-Dependent Cytotoxicity (K-Cell Activity) -- I. Introduction. , II. Model Studies with Effector Cells from Nonimmune Donors -- III. K-Cell Activity in Different Immune Systems -- References -- Chapter 8. Short-Term 51Cr-Release Tests for Direct Cell-Mediated Cytotoxicity: Methods, Clinical Uses, and Interpretations -- I. Introduction -- II. Pathways for Direct Cell-Mediated Cytotoxicity -- III. Methodology -- IV. Examples of Clinical Applications -- V. Interpretive Limitations -- VI. Some Future Applications -- VII. Concluding Comments -- Acknowledgments -- References -- Chapter 9. Lymphocyte Transformation in Vitro in Response to Mitogens and Antigens -- I. Introduction -- II. Lymphocyte Activation: Specific or Nonspecific -- III. Characteristics of the Reaction -- IV. Regulation of the Reaction -- V. Lymphocyte Transformation in Vitro in Clinical Immunology -- References -- Chapter 10. Products of Activated Lymphocytes -- I. Introduction -- II. Cell Migration Inhibition System -- III. Macrophage Activation by Lymphocyte Mediators -- IV. Macrophage (Monocyte) Chemotactic Factor -- V. Lymphocyte Mitogenic ( Blastogenic ) Factors -- VI. Cytotoxic Factors ( Lymphotoxins ) -- VII. Interferon -- VIII. Summary -- References -- Chapter 11. Leukocyte Aggregation Test for Evaluating Cell-Mediated Immunity -- I. Introduction -- II. Method -- III. Results -- IV. Discussion -- Acknowledgments -- References -- Chapter 12. The HLA System: Serologically Defined Antigens -- I. The HLA System: Serologically Defined Antigens -- II. HLA and Transplantation -- III. HLA and Disease -- IV. Clinical Applications -- References -- Chapter 13. Mixed Leukocyte Cultures: A Cellular Approach to Histocompatibility Testing -- I. Introduction -- II. Methods -- III. Results -- IV. Clinical Usefulness of Mixed Leukocyte Culture Testing -- V. Addendum -- References -- Chapter 14. The Reticuloendothelial System -- I. Introduction. , II. Clearance Testing -- III. Rebuck Skin Windows -- IV. Cellular Studies -- References -- Chapter 15. Assessment of Allergic States: IgE Methodology and the Measurement of Allergen-Specific IgG Antibody -- I. Introduction -- II. Total Serum IgE -- III. Allergen-Specific IgE -- IV. Allergen-Specific IgG Antibodies -- V. Conclusions -- Selected References -- Chapter 16. Autoantibodies in Hematological Disorders -- I. Introduction -- II. Autoimmune Hemolytic Anemia -- III. Autoantibodies against Thrombocytes -- IV. Autoantibodies against Leukocytes -- Appendix -- References -- Chapter 17. Rheumatoid Factors in Human Disease -- I. Introduction -- II. General Test Procedures -- III. Clinical Significance -- Appendix: Commonly Used Rheumatoid Factor Tests -- References -- Chapter 18. Antibodies to Nucleic Acids -- I. Introduction -- II. Performance of the Tests -- III. Results and Interpretation -- IV. Differential Diagnosis -- References -- Chapter 19. Complement -- I. Introduction -- II. Complement Components and Activation Sequence -- III. Biological Activities of Complement -- IV. Tests Involving Complement -- V. Complement-Fixation Tests -- VI. Miscellaneous Tests -- VII. Complement Abnormalities in Disease -- VIII. Inherited Disorders of the Complement System -- References -- Chapter 20. Detection of Tumor-Associated Antigens in Plasma or Serum -- I. Introduction -- II. α-Fetoprotein -- III. Carcinoembryonic Antigen -- IV. Other Antigens, Antibodies -- V. Conclusion -- References -- Chapter 21. Neutrophil Function -- I. Introduction -- II. Phagocytosis -- III. Bactericidal Assays of Neutrophils -- IV. Assays of Neutrophil Movement -- References -- Subject Index.